Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Cardium Therapeutics Inc. (CRXM) had Debt to Equity Ratio of -0.13 for the most recently reported fiscal quarter, ending 2020-12-31.
| Income Statement Financials | |
-- |
|
$-0.44M |
|
-- |
|
-- |
|
$1.08M |
|
$-1.08M |
|
$0.59M |
|
$-0.49M |
|
$-1.09M |
|
$-0.49M |
|
$-0.49M |
|
$-0.49M |
|
$-1.09M |
|
$-1.08M |
|
$-1.07M |
|
24.12M |
|
24.12M |
|
$-0.03 |
|
$0.01 |
|
| Balance Sheet Financials | |
$0.41M |
|
$0.00M |
|
$0.16M |
|
$0.57M |
|
$5.03M |
|
$0.03M |
|
$0.11M |
|
$5.14M |
|
$-4.57M |
|
$-4.57M |
|
$-4.57M |
|
40.33M |
|
| Cash Flow Statement Financials | |
$-1.13M |
|
$-0.00M |
|
$1.52M |
|
$0.00M |
|
$0.39M |
|
$0.39M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.08 |
|
-- |
|
-- |
|
-0.01 |
|
|
Debt to Equity Ratio |
-0.13 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.14M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
10.72% |
|
10.72% |
|
-86.34% |
|
10.78% |
|
$-0.11 |
|
$-0.05 |
|
$-0.05 |
|